Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Landvogt

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Neuro-Degenerative Diseases|July 10, 2010
Importance of 123I-metaiodobenzylguanidine scintigraphy/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromesWolfgang H Jost, Kelly Del Tredici, Christian Landvogt, et al.
Epilepsia|April 14, 2010
Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsyChristian Landvogt, Hans-Georg Buchholz, Viviane Bernedo, et al.
Acta Crystallographica. Section E, Crystallographic Communications|May 22, 2015
Crystal structure of 4-hy-droxy-3-meth-oxy-benzaldehyde 4-methyl-thio-semi-carbazone methanol monosolvateAdriano Bof de Oliveira, Johannes Beck, Christian Landvogt, et al.
Cancers|June 13, 2025
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand TherapyCarsten S Kramer, Aleksandr Eismant, Aditi Mishra, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 24, 2015
Crystal structure of (E)-2-[4-(4-hy-droxy-phen-yl)butan-2-yl-idene]hydrazine-1-carbo-thio-amideAdriano Bof de Oliveira, Johannes Beck, Christian Landvogt, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 21, 2017
Crystal structure of <i>N</i>-ethyl-2-(1,2,3,4-tetra-hydro-naphthalen-1-yl-idene)hydrazinecarbo-thio-amideAdriano Bof de Oliveira, Johannes Beck, Christian Landvogt, et al.
Iscience|December 13, 2023
3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, et al.
Theranostics|February 24, 2025
First-in-human study of an optimized, potential kit-type, SSTR antagonist <sup>68</sup>Ga-DATA<sup>5m</sup>-LM4 in patients with metastatic neuroendocrine tumorsJingjing Zhang, Lukas Greifenstein, Vivianne Jakobsson, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPiLukas Greifenstein, Carsten S Kramer, Euy Sung Moon, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3Lukas Greifenstein, Marcel Martin, Sarah Stephan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Neuro-Degenerative Diseases|July 10, 2010
Importance of 123I-metaiodobenzylguanidine scintigraphy/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromesWolfgang H Jost, Kelly Del Tredici, Christian Landvogt, et al.
Epilepsia|April 14, 2010
Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsyChristian Landvogt, Hans-Georg Buchholz, Viviane Bernedo, et al.
Acta Crystallographica. Section E, Crystallographic Communications|May 22, 2015
Crystal structure of 4-hy-droxy-3-meth-oxy-benzaldehyde 4-methyl-thio-semi-carbazone methanol monosolvateAdriano Bof de Oliveira, Johannes Beck, Christian Landvogt, et al.
Cancers|June 13, 2025
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand TherapyCarsten S Kramer, Aleksandr Eismant, Aditi Mishra, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 24, 2015
Crystal structure of (E)-2-[4-(4-hy-droxy-phen-yl)butan-2-yl-idene]hydrazine-1-carbo-thio-amideAdriano Bof de Oliveira, Johannes Beck, Christian Landvogt, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 21, 2017
Crystal structure of <i>N</i>-ethyl-2-(1,2,3,4-tetra-hydro-naphthalen-1-yl-idene)hydrazinecarbo-thio-amideAdriano Bof de Oliveira, Johannes Beck, Christian Landvogt, et al.
Iscience|December 13, 2023
3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, et al.
Theranostics|February 24, 2025
First-in-human study of an optimized, potential kit-type, SSTR antagonist <sup>68</sup>Ga-DATA<sup>5m</sup>-LM4 in patients with metastatic neuroendocrine tumorsJingjing Zhang, Lukas Greifenstein, Vivianne Jakobsson, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPiLukas Greifenstein, Carsten S Kramer, Euy Sung Moon, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3Lukas Greifenstein, Marcel Martin, Sarah Stephan, et al.
Pageof 3